


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+22.23%
+10.11%
+2.46%
CNTB
Connect Biopharma Holding
$2.66
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
CNTB Price Performance
$1.71 (+55.56%)
$1.78 (+49.44%)
$1.09 (+144.04%)
$1.12 (+137.50%)
CNTB has Medium risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

Low volume

High volatilty

CNTB overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
CNTB Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
CNTB Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is CNTB current stock price?
What are CNTB stock strengths?
What is CNTB Risk Level?
What is CNTB market cap and volume?
What is CNTB current Stock IQ?
Should I buy CNTB stock right now?
Is CNTB a Strong Buy right now?
What does a 'Strong Buy' rating mean for CNTB?
What does a 'Strong Sell' rating mean for CNTB?
What factors influence CNTB's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+22.23%
+10.11%
+2.46%
CNTB
Connect Biopharma Holding
Current Price
$2.66
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

CNTB Price Performance
$1.71 (+55.56%)
$1.78 (+49.44%)
$1.09 (+144.04%)
$1.12 (+137.50%)
CNTB Analysts Opinion
CNTB Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
CNTB Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
CNTB Street Sentiment is extremely bullish and have positive views on the near-term outlook
CNTB has Medium risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

Low volume

High volatilty

Average key support and resistance price levels
CNTB Stock IQ
CNTB Latest Analysis
Lake Street Initiates Coverage of Connect Biopharma Holdings Limited - Depositary Receipt (CNTB) with Buy Recommendation. Fintel reports that on December 1 2025 Lake Street initiated coverage of Connect Biopharma Holdings Limited - Depositary Receipt (NasdaqGM:CNTB) with a Buy recommendation. Analyst Price Forecast Suggests 179.77% Upside
Tue Dec 2, 2025
Connect Biopharma Holdings Limited - Depositary Receipt (CNTB) Price Target Increased by 11.59% to 7.78. The average one-year price target for Connect Biopharma Holdings Limited - Depositary Receipt (NasdaqGM:CNTB) has been revised to $7.78 / share. This is an increase of 11.59% from the prior estimate of $6.97 dated November 7 2025. The price target is an avera
Mon Nov 17, 2025
BTIG Reiterates Connect Biopharma Holdings Limited - Depositary Receipt (CNTB) Buy Recommendation. Fintel reports that on November 13 2025 BTIG reiterated coverage of Connect Biopharma Holdings Limited - Depositary Receipt (NasdaqGM:CNTB) with a Buy recommendation. Analyst Price Forecast Suggests 332.92% Upside
Thu Nov 13, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CNTB Stock trends
CNTB Stock performance
CNTB Stock analysis
CNTB investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.